title: [Revision consensus osteoporosis].
abstract: Several years ago a consensus guideline conference was organised both in the United States (1984) and in the Netherlands (1985) on case finding, prevention and treatment of osteoporosis. The most important conclusion of both conferences was that oestrogen substitution can significantly reduce the incidence of fractures in postmenopausal women. This statement has not changed in the revised guidelines on osteoporosis of 1991. As far as the effect of hormonal substitution of oestrogens with or without progestagens in relation to cardiovascular disease and breast and endometrial carcinoma is concerned, insights have hardly changed in the last 5 years. The value of other drugs in the treatment of osteoporosis, however, has become better known. Both diphosphonates and anabolic steroids have recently made a comeback.
authors.forename: J H
authors.initials: JH
authors.lastname: Lockefeer
mesh_terms: D045930:Anabolic Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D045930:Anabolic Agents; D004164:Diphosphonates
vernacular_title: Herziening consensus osteoporose.